Literature DB >> 8123051

Rottlerin, a novel protein kinase inhibitor.

M Gschwendt1, H J Müller, K Kielbassa, R Zang, W Kittstein, G Rincke, F Marks.   

Abstract

Rottlerin, a compound from Mallotus philippinensis, is shown to inhibit protein kinases with some specificity for PKC. To some extent, the novel inhibitor is able to differentiate between PKC isoenzymes, with IC50 values for PKC delta of 3-6 microM, PKC alpha,beta,gamma of 30-42 microM and PKC epsilon,eta,zeta of 80-100 microM. Inhibition of PKC appears, at least in part, to be due to a competition between rottlerin and ATP. Among the protein kinases tested, only CaM-kinase III is suppressed by rottlerin as effectively as PKC delta. The chemical structure of rottlerin might serve as a basis for the development of novel inhibitors with improved selectivity for a distinct PKC isoenzyme, such as PKC delta, or for CaM-kinase III.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8123051     DOI: 10.1006/bbrc.1994.1199

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  253 in total

1.  Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase.

Authors:  A Rahman; K N Anwar; S Uddin; N Xu; R D Ye; L C Platanias; A B Malik
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Protein kinase C-delta C2-like domain is a binding site for actin and enables actin redistribution in neutrophils.

Authors:  G López-Lluch; M M Bird; B Canas; J Godovac-Zimmerman; A Ridley; A W Segal; L V Dekker
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

3.  The many hats of protein kinase Cδ: one enzyme with many functions.

Authors:  Nir Qvit; Daria Mochly-Rosen
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

4.  Alterations in protein kinase C activity and processing during zinc-deficiency-induced cell death.

Authors:  Susan S Chou; Michael S Clegg; Tony Y Momma; Brad J Niles; Jodie Y Duffy; George P Daston; Carl L Keen
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

5.  Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.

Authors:  Koji Nobe; Mari Miyatake; Hiromi Nobe; Yasushi Sakai; Junko Takashima; Kazutaka Momose
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

6.  Monocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity.

Authors:  Ashish Bhattacharjee; Anny Mulya; Srabani Pal; Biswajit Roy; Gerald M Feldman; Martha K Cathcart
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

7.  Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors.

Authors:  S Ayabe; T Murata; T Maruyama; M Hori; H Ozaki
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

8.  Phosphorylation-regulated nucleocytoplasmic trafficking of internalized fibroblast growth factor-1.

Authors:  Antoni Wiedłocha; Trine Nilsen; Jørgen Wesche; Vigdis Sørensen; Jedrzej Małecki; Ewa Marcinkowska; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

9.  Phosphoinositide-dependent kinase-1 and protein kinase Cδ contribute to endothelin-1 constriction and elevated blood pressure in intermittent hypoxia.

Authors:  Bradley R Webster; Jessica M Osmond; Daniel A Paredes; Xavier A DeLeon; Olan Jackson-Weaver; Benjimen R Walker; Nancy L Kanagy
Journal:  J Pharmacol Exp Ther       Date:  2012-10-23       Impact factor: 4.030

10.  CGX1037 is a novel PKC isoform delta selective inhibitor in platelets.

Authors:  Dheeraj Bhavanasi; John C Kostyak; John Swindle; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  Platelets       Date:  2014-01-16       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.